324 related articles for article (PubMed ID: 17516311)
21. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
[TBL] [Abstract][Full Text] [Related]
22. [Surgical therapy for esophageal carcinoma: a prospective 20-year analysis].
Gockel I; Sultanov FS; Domeyer M; Trinh TT; Gönner U; Junginger T
Zentralbl Chir; 2008 Jun; 133(3):260-6. PubMed ID: 18563693
[TBL] [Abstract][Full Text] [Related]
23. [Treatment and prognosis of primary esophageal small cell carcinoma: a report of 151 cases].
Song Y; Wang LH; He J; Wang JW
Ai Zheng; 2009 Mar; 28(3):303-7. PubMed ID: 19619447
[TBL] [Abstract][Full Text] [Related]
24. [Squamous cell cancer of the esophagus. Treatment concept at the National Cancer Center in Tokyo].
Watanabe H
Chirurg; 1992 Sep; 63(9):689-92. PubMed ID: 1395873
[No Abstract] [Full Text] [Related]
25. Transthoracic vs. transhiatal esophagectomy: Stage migration muddies the water.
Block MI
J Surg Oncol; 2006 Jun; 93(7):519-20. PubMed ID: 16705733
[No Abstract] [Full Text] [Related]
26. Effect of chemoradiotherapy for neural invasion in an advanced esophageal cancer.
Tanaka A; Ishikawa S; Okuno K; Shiozaki H
Hepatogastroenterology; 2008; 55(84):963-6. PubMed ID: 18705308
[TBL] [Abstract][Full Text] [Related]
27. [Esophageal carcinoma].
Siewert JR
Chirurg; 2007 May; 78(5):475-84; quiz 485. PubMed ID: 17447037
[TBL] [Abstract][Full Text] [Related]
28. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of oesophageal cancer.
Veuillez V; Rougier P; Seitz JF
Best Pract Res Clin Gastroenterol; 2007; 21(6):947-63. PubMed ID: 18070697
[TBL] [Abstract][Full Text] [Related]
29. [Esophageal tumors--therapeutic problems].
Hellriegel W
Strahlentherapie; 1972 Sep; 144(3):276-86. PubMed ID: 4117445
[No Abstract] [Full Text] [Related]
30. [Discussion of the treatment of esophageal carcinoma,especially in the point of non-surgical treatments, from the viewpoint of medical oncology].
Maeda Y; Sasaki E; Sasaki T
Gan To Kagaku Ryoho; 2007 Jun; 34(6):831-5. PubMed ID: 17565242
[TBL] [Abstract][Full Text] [Related]
31. Multi-modality treatment in oesophageal cancer: a curse for radiotherapy progress.
Tait DM
Radiother Oncol; 2004 Nov; 73(2):115-7. PubMed ID: 15542157
[No Abstract] [Full Text] [Related]
32. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
[TBL] [Abstract][Full Text] [Related]
33. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
34. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Teoh AY; Chiu PW; Wong SK; Ng EK
Ann Surg; 2010 Jan; 251(1):186-7. PubMed ID: 19935402
[No Abstract] [Full Text] [Related]
35. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.
Zehetner J; DeMeester SR
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671
[TBL] [Abstract][Full Text] [Related]
36. Effect of tumor characteristics and duplication of the muscularis mucosae on the endoscopic staging of superficial Barrett esophagus-related neoplasia.
Mandal RV; Forcione DG; Brugge WR; Nishioka NS; Mino-Kenudson M; Lauwers GY
Am J Surg Pathol; 2009 Apr; 33(4):620-5. PubMed ID: 19047893
[TBL] [Abstract][Full Text] [Related]
37. Closing the loop around esophagectomy after neoadjuvant therapy.
Demeester SR
Ann Surg; 2009 Sep; 250(3):500; author reply 500. PubMed ID: 19730188
[No Abstract] [Full Text] [Related]
38. Neoadjuvant chemotherapy and surgery for esophageal adenocarcinoma: prognostic value of circumferential resection margin and stratification of N1 category.
Saha AK; Sutton C; Rotimi O; Dexter S; Sue-Ling H; Sarela AI
Ann Surg Oncol; 2009 May; 16(5):1364-70. PubMed ID: 19252949
[TBL] [Abstract][Full Text] [Related]
39. [Malignant epibulbar tumours: new strategies in diagnostics and therapy].
Westekemper H; Schallenberg M; Tomaszewski A; Nückel H; Sauerwein W; Meller D; Steuhl K
Klin Monbl Augenheilkd; 2011 Sep; 228(9):780-92. PubMed ID: 21487989
[TBL] [Abstract][Full Text] [Related]
40. [The definitive radiochemotherapy in patients with T4 and/or M1 (lymph node) squamous-cell carcinoma of the esophagus].
Mücke R; Fietkau R
Strahlenther Onkol; 2000 Aug; 176(8):384-5. PubMed ID: 10987025
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
